Their mission is fueled by their belief in open science principles and creating global public-private partnerships among governmental, corporate, scientific and philanthropic communities.
Co-located in Rehovot, Israel and Richmond, Va., ImmunArray is a privately funded molecular diagnostics company dedicated to the development of novel blood-based tests that support the diagnosis and management of complex acute and chronic immune and neurodegenerative diseases. The company designs and analyzes sets of biomarkers known to be linked to a particular condition and develops tests on platforms that are most appropriate to facilitate the adoption of additional tests. The company, which introduced its first commercial tests, is currently conducting research in collaboration with leading clinicians and medical centers in the U.S. and Israel. The company was a grant recipient of the GE-NFL Head Health Challenge as well as secured additional corporate research funding to conduct research into the use of biomarkers to identify traumatic brain injury.
INCF is an international non-profit organization devoted to advancing the field of neuroinformatics.
INCF Community consists of our 17 member countries and associated research groups, consortia, funding agencies and publishers in the field.
The National Nodes are institutions or networks that represent each member country. The nodes are established to coordinate neuroinformatics activity within a country and to provide a connection with the Secretariat. Furthermore, they play an active role in formulating and implementing INCF Programs.
The Secretariat, located in Stockholm Sweden, is the central office of INCF and is responsible for overall scientific and administrative activities. It assists the National Nodes and plays an active role in furthering neuroinformatics through outreach.
The Governing Board is composed of representatives from the member countries and is the means by which the nodes make collective decisions regarding INCF. The European Union is also represented in the Board.
The Society of Hospital Medicine (SHM) is a professional medical society representing more than 13,000 of the 44,000 practicing hospitalists in the U.S. dedicated to providing exceptional care to the hospitalized patient.
SynkThink is a neuro-technology company with foundational intellectual property in eye-tracking metrics and devices. The Company was founded in 2008 and is headquartered in Palo Alto, California.
SYNCTHINK was founded by Dr. Jam Ghajar, a clinical professor of neurosurgery at Stanford and founder and director of its Concussion and Brain Performance Center. He is also the founder of the Brain Trauma Foundation. Other notable board members include Alan Quasha, Ernie Santin, Kevin Quinn, and John van Merkensteijn.
SyncThink sells its diagnostic device under the EYE-SYNC label. The EYE-SYNC is a high-performance device that uses virtual reality to assess abnormal eye movement, which is a common occurrence after a concussion. The device comes in a portable suitcase that can be used in a clinical setting or outdoors.
The EYE-SYNC received FDA clearance in January, 2016 to market the technology as a medical device.
The device is currently used by Stanford University as well as various other institutions.
Violence prevention and intervention programs are a powerful way to stop the revolving door of violent injury in our hospitals. Engaging patients in the hospital, during their recovery, is a golden opportunity to change their lives and reduce retaliation and recidivism.
The National Network of Hospital-based Violence Intervention Programs (NNHVIP) brings together the best and most exciting programs to share knowledge, develop best practices, collaborate on research, affect policy change, and more.
Whether you are just thinking about starting a program, a new and emerging program, or have an established program; NNHVIP is here to help you reach your goals. Get in touch today!